Pediatric Oncology Flashcards
Acute Leukemias
- Myeloid or Lymphoid
- Most Pediatric Acute Leukemias have
NO clear cause
What differentiates the Two main types of Acute Leukemia?
- Epidemiology is different
- Diagnostic findings are Similar, a few important differences
Pathophysiology of ALL
Lymphoid Progenitor Cells
in the bone marrow become
malignant & begin to proliferate
uncontrolled
Pathophysiology of AML
Myeloid Progenitor Cells become malignant & proliferate uncontrolled
_____ = MOST COMMON childhood malignancy!
ALL
ALL epidemiology
- Incidence of ALL peaks at the age of 5 years (3-7)
■ ALL = MOST COMMON childhood malignancy! - Incidence ↓ after 5 yo, then ↑ after 50 yo
- 80% in kids
- 20% in adults
Epidemiology of AML
- 80% of all new cases of
ADULT leukemias - Adults over 50 years
of age (mean = 60) - It can occur in children & young adults, but less often
Which leukemia is associated with Trisomy 21?
AML
Clinical Presentation (AML & ALL)
- Chief complaint may be fever, fatigue,
weight loss, irritability, arthralgias,
bleeding
(often the gums → “pink in the sink”) - If CNS involvement, may have headache,
stiff neck, visual disturbances,
or vomiting - Gingival hypertrophy from leukemic
infiltration is common
Physical exam of ALL and AML may reveal:
○ Pallor
○ Petechiae
○ Ecchymosis
○ Papilledema
○ Retinal hemorrhages
○ Focal neurologic deficits
○ Hepatomegaly (more common in ALL)
○ Splenomegaly (more common in ALL)
○ Lymphadenopathy (more common in ALL)
You are more likely to see hepatomegaly, splenomegaly and lymphadenopathy in ____
ALL
Hyperleukocytosis
■ High circulating blasts in the blood
leads to clumping blasts in capillaries
● Impaired circulation
● Headache, confusion, dyspnea
● Tx = emergent leukapheresis
& chemotherapy
● MOST EXTREME presentation
MOST EXTREME presentation in AML and ALL?
Hyperleukocytosis
Diagnosis of Acute leukemias
- Bone Marrow Biopsy
○ Hypercellular
■ > 20% Blasts - CBC
o Normocytic anemia
o Thrombocytopenia
o Often neutropenia - WBC count can be low, normal, or high
- Chest x-ray
- ALL
- Possible Anterior Mediastinal mass
○ specifically T-cell ALL - Peripheral Blood Smear in
AML may show Auer Rods
Hallmark of both AML and ALL?
- Pancytopenia and circulating blasts
- Lymphoid or myeloid
CNS infiltration is common in ____
ALL
Management & Referral of Acute leukemias
- Acute Leukemia tx’d by Hematology Oncology
- Treatment for both ALL & AML includes “Induction Chemotherapy”
- CNS infiltration is common in ALL
- Intrathecal chemotherapy
What is “Induction Chemotherapy”?
- aggressive combination chemo
- goal = “inducing” remission
Childhood ALL – ___ % tx
success within 4 weeks
98
Adult ALL & AML outcomes
- Remission ~60-80%
- Complete cure is less likely in adults
Hodgkin’s Lymphoma epidemiology
● Bimodal age distribution
1. ↑ incidence in young-teen to young-adulthood
■ Average around 20 years of age (20’s)
2. 2nd peak occurs later in life at about 50 years of age (50’s)
● ~85 % male
Characterized by the presence of
Reed-Sternberg cells
Hodgkin’s Lymphoma
Some studies have suggested a
correlation between EBV infection
& lymphomas with _____
Hodgkin’s Lymphoma
Hodgkin’s Lymphoma Pathophysiology
○ Starts in a localized region of lymph
nodes
○ Spreads in an orderly, predictable
fashion to adjacent sites of lymph tissue
■ Opposite of Non-Hodgkin’s
○ Often starts in the cervical or
supraclavicular regions
Hodgkin’s Lymphoma Presentation
■ Painless lump in neck area
■ Fevers/chills
■ Night sweats
■ Weight loss
■ Anorexia
■ General malaise
■ Excessive fatigue in children
○ May report a febrile pattern called Pel-Ebstein pattern
Interestingly, adults with Hodgkin’s will
experience pain/soreness at lymph
node with _____
ETOH ingestion
Hodgkin’s Lymphoma diagnosis
Lymph node biopsy
■ Excisional biopsy is preferred over fine-needle aspiration
○ CT chest/abdomen/pelvis required for Ann Arbor Staging
Management & Referral of Hodgkin’s Lymphoma
○ General surgeon or ENT surgeon for biopsy
○ If diagnosis is established, contact Oncology right away to set up consultation
Prognosis of Hodgkin’s Lymphoma
■ 5 year survival rate for Stage 1 is > 95%
● For Stage 4, about 65%
Non-Hodgkin’s Lymphoma
A group of dozens of forms of Lymphoma all classified as
Non-Hodgkin’s Lymphoma (Non-Hodgkin’s Disease)